The present invention concerns fixed dosing of HER antibodies, such as Pertuzumab.

 
Web www.patentalert.com

< Polypeptides derived from anti-HIV-1 gp120 antibodies that abrogate gp120 binding to CCR5

> Methods of blocking the interaction between stromal cells and hemopoietic cells with anti-VCAM-1 antibodies
~ 00473